242 related articles for article (PubMed ID: 16376101)
1. Suppression of anti-cancer immunity by regulatory T cells: back to the future.
Orentas RJ; Kohler ME; Johnson BD
Semin Cancer Biol; 2006 Apr; 16(2):137-49. PubMed ID: 16376101
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cells in immune surveillance and treatment of cancer.
Yamaguchi T; Sakaguchi S
Semin Cancer Biol; 2006 Apr; 16(2):115-23. PubMed ID: 16376102
[TBL] [Abstract][Full Text] [Related]
3. Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer.
Wang RF
Semin Cancer Biol; 2006 Feb; 16(1):73-9. PubMed ID: 16140545
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.
Yamazaki S; Inaba K; Tarbell KV; Steinman RM
Immunol Rev; 2006 Aug; 212():314-29. PubMed ID: 16903923
[TBL] [Abstract][Full Text] [Related]
5. The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer.
Khazaie K; von Boehmer H
Semin Cancer Biol; 2006 Apr; 16(2):124-36. PubMed ID: 16443370
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells: potential target in anticancer immunotherapy.
Juang CM; Hung CF; Yeh JY; Horng HC; Twu NF; Cheng MH; Wen KC; Yuan CC; Chao KC; Wu TC; Yen MS
Taiwan J Obstet Gynecol; 2007 Sep; 46(3):215-21. PubMed ID: 17962099
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells and cancer.
Wang HY; Wang RF
Curr Opin Immunol; 2007 Apr; 19(2):217-23. PubMed ID: 17306521
[TBL] [Abstract][Full Text] [Related]
8. Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms.
Lizée G; Radvanyi LG; Overwijk WW; Hwu P
Clin Cancer Res; 2006 Aug; 12(16):4794-803. PubMed ID: 16914564
[TBL] [Abstract][Full Text] [Related]
9. Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma.
Meloni F; Morosini M; Solari N; Passadore I; Nascimbene C; Novo M; Ferrari M; Cosentino M; Marino F; Pozzi E; Fietta AM
Hum Immunol; 2006; 67(1-2):1-12. PubMed ID: 16698419
[TBL] [Abstract][Full Text] [Related]
10. CD4+CD25+ regulatory T cells in human hematopoietic cell transplantation.
Zorn E
Semin Cancer Biol; 2006 Apr; 16(2):150-9. PubMed ID: 16431128
[TBL] [Abstract][Full Text] [Related]
11. Adoptive cell therapy using in vitro generated human CD4+ CD25+ regulatory t cells with indirect allospecificity to promote donor-specific transplantation tolerance.
Jiang S; Tsang J; Lechler RI
Transplant Proc; 2006 Dec; 38(10):3199-201. PubMed ID: 17175221
[TBL] [Abstract][Full Text] [Related]
12. Regulatory cells and human cancer.
Baecher-Allan C; Anderson DE
Semin Cancer Biol; 2006 Apr; 16(2):98-105. PubMed ID: 16378733
[TBL] [Abstract][Full Text] [Related]
13. Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.
Schabowsky RH; Madireddi S; Sharma R; Yolcu ES; Shirwan H
Curr Opin Investig Drugs; 2007 Dec; 8(12):1002-8. PubMed ID: 18058571
[TBL] [Abstract][Full Text] [Related]
14. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses.
Venken K; Thewissen M; Hellings N; Somers V; Hensen K; Rummens JL; Stinissen P
J Immunol Methods; 2007 Apr; 322(1-2):1-11. PubMed ID: 17368474
[TBL] [Abstract][Full Text] [Related]
15. Human regulatory T cells and their role in autoimmune disease.
Baecher-Allan C; Hafler DA
Immunol Rev; 2006 Aug; 212():203-16. PubMed ID: 16903916
[TBL] [Abstract][Full Text] [Related]
16. CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastoma.
Johnson BD; Jing W; Orentas RJ
J Immunother; 2007; 30(2):203-14. PubMed ID: 17471167
[TBL] [Abstract][Full Text] [Related]
17. Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10.
Larmonier N; Marron M; Zeng Y; Cantrell J; Romanoski A; Sepassi M; Thompson S; Chen X; Andreansky S; Katsanis E
Cancer Immunol Immunother; 2007 Jan; 56(1):48-59. PubMed ID: 16612596
[TBL] [Abstract][Full Text] [Related]
18. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulatory T cells in tumor immunity.
Terabe M; Berzofsky JA
Curr Opin Immunol; 2004 Apr; 16(2):157-62. PubMed ID: 15023407
[TBL] [Abstract][Full Text] [Related]
20. CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells.
Campanelli AP; Roselino AM; Cavassani KA; Pereira MS; Mortara RA; Brodskyn CI; Goncalves HS; Belkaid Y; Barral-Netto M; Barral A; Silva JS
J Infect Dis; 2006 May; 193(9):1313-22. PubMed ID: 16586370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
